Skip navigation
Skip navigation

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells

Avery, Danielle T.; Kalled, Susan L.; Ellyard, Julia I.; Ambrose, Christine; Bixler, Sarah A.; Thien, Marilyn; Brink, Robert; Mackay, Fabienne; Hodgkin, Philip D.; Tangye, Stuart G.

Description

The generation of Ig-secreting cells (ISCs) from memory B cells requires interactions between antigen-specific (Ag-specific) B cells, T cells, and dendritic cells. This process must be strictly regulated to ensure sufficient humoral immunity while avoiding production of pathogenic autoantibodies. BAFF, a member of the TNF family, is a key regulator of B cell homeostasis. BAFF exerts its effect by binding to three receptors — transmembrane activator of and CAML interactor (TACI), B cell...[Show more]

dc.contributor.authorAvery, Danielle T.
dc.contributor.authorKalled, Susan L.
dc.contributor.authorEllyard, Julia I.
dc.contributor.authorAmbrose, Christine
dc.contributor.authorBixler, Sarah A.
dc.contributor.authorThien, Marilyn
dc.contributor.authorBrink, Robert
dc.contributor.authorMackay, Fabienne
dc.contributor.authorHodgkin, Philip D.
dc.contributor.authorTangye, Stuart G.
dc.date.accessioned2016-03-21T03:30:13Z
dc.date.available2016-03-21T03:30:13Z
dc.identifier.issn0021-9738
dc.identifier.urihttp://hdl.handle.net/1885/100838
dc.description.abstractThe generation of Ig-secreting cells (ISCs) from memory B cells requires interactions between antigen-specific (Ag-specific) B cells, T cells, and dendritic cells. This process must be strictly regulated to ensure sufficient humoral immunity while avoiding production of pathogenic autoantibodies. BAFF, a member of the TNF family, is a key regulator of B cell homeostasis. BAFF exerts its effect by binding to three receptors — transmembrane activator of and CAML interactor (TACI), B cell maturation antigen (BCMA), and BAFF receptor (BAFF-R). To elucidate the contribution of BAFF to the differentiation of B cells into ISCs, we tracked the fate of human memory B cells stimulated with BAFF or CD40L. BAFF and CD40L significantly increased the overall number of surviving B cells. This was achieved via distinct mechanisms. CD40L induced proliferation of nondifferentiated blasts, while BAFF prevented apoptosis of ISCs without enhancing proliferation. The altered responsiveness of activated memory B cells to CD40L and BAFF correlated with changes in surface phenotype such that expression of CD40 and BAFF-R were reduced on ISCs while BCMA was induced. These results suggest BAFF may enhance humoral immunity in vivo by promoting survival of ISCs via a BCMA-dependent mechanism. These findings have wide-ranging implications for the treatment of human immunodeficiencies as well as autoimmune diseases.
dc.description.sponsorshipThis work was supported by the National Health and Medical Research Council of Australia. S.G. Tangye was supported by a U2000 Postdoctoral Fellowship awarded by the University of Sydney. P.D. Hodgkin is a Senior Research Fellow of the National Health and Medical Research Council of Australia. F. Mackay is a Wellcome Trust Senior Research Fellow.
dc.publisherAmerican Society for Clinical Investigation
dc.rightshttp://www.sherpa.ac.uk/romeo/issn/0021-9738..."author can archive publisher's version/PDF. Authors personal websites, institutional repositories and funding-body repositories" from SHERPA/RoMEO site (as at 21/03/16).
dc.sourceJournal of Clinical Investigation
dc.subjectKeywords: B cell maturation antigen; BAFF receptor; CD40 ligand; immunoglobulin; protein BAFF; receptor; transmembrane activator and CAML interactor; tumor necrosis factor; unclassified drug; adenosine diphosphate ribosyl cyclase; ANP32B protein, human; B cell acti
dc.titleBAFF selectively enhances the survival of plasmablasts generated from human memory B cells
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume112
dc.date.issued2003
local.identifier.absfor060802
local.identifier.ariespublicationu4133361xPUB86
local.type.statusPublished Version
local.contributor.affiliationAvery, Danielle T, Garvan Institute of Medical Research, Australia
local.contributor.affiliationKalled, Susan L, Biogen Idec Inc, United States of America
local.contributor.affiliationEllyard, Julia, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Immunology and Infectious Disease, The Australian National University
local.contributor.affiliationAmbrose, Christine, Biogen Idec Inc, United States of America
local.contributor.affiliationBixler, Sarah A, Biogen Idec Inc., United States of America
local.contributor.affiliationThien, Marilyn, Garvan Institute of Medical Research, Australia
local.contributor.affiliationBrink, Robert, Garvan Institute of Medical Research, Australia
local.contributor.affiliationMackay, Fabienne, Garvan Institute of Medical Research, Australia
local.contributor.affiliationHodgkin, Phillip D, University of Sydney, Australia
local.contributor.affiliationTangye, Stuart, Garvan Institute of Medical Research, Australia
local.bibliographicCitation.issue2
local.bibliographicCitation.startpage286
local.bibliographicCitation.lastpage297
local.identifier.doi10.1172/JCI18025
dc.date.updated2016-06-14T08:59:03Z
local.identifier.scopusID2-s2.0-0041742400
dcterms.accessRightsOpen Access
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Avery_BAFF_selectively_enhances_the_2003.pdfPublished Version1.15 MBAdobe PDFThumbnail


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator